Select a medication above to begin.
Avlayah (tividenofusp alfa-eknm)
tividenofusp alfa
Black Box Warnings .
Hypersensitivity Reaction
life-threatening reactions including anaphylaxis have occurred; anaphylaxis has occurred during early tx and after extended tx duration; initiate tx in healthcare setting where appropriate medical support including cardiopulmonary resuscitation equipment available; D/C immediately and start appropriate tx if severe reaction occurs; counsel patients on signs/symptoms and to seek immediate medical attention if they occur at any time
Adult Dosing .
Adult dosing is currently unavailable or not applicable for this drug.
Peds Dosing .
- Dosage forms: INJ
Special Note
- [drug name clarification]
- Info: nonproprietary name = tividenofusp alfa-eknm
mucopolysaccharidosis II
- [>5 kg]
- Dose: 15 mg/kg/dose IV qwk; Start: 3 mg/kg/dose IV qwk for at least 4wk, then 7.5 mg/kg/dose IV qwk for at least 4wk; Info: for neurologic manifestations when begun before advanced impairment; consider premed with antihistamine, antipyretic, and/or corticosteroid
renal dosing
- [not defined]
- renal impairment: not defined
- HD/PD: not defined
hepatic dosing
- [not defined]